{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:51:37Z","timestamp":1782917497117,"version":"3.54.5"},"reference-count":34,"publisher":"Society of Nuclear Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,3,25]]},"published-print":{"date-parts":[[2026,7]]},"DOI":"10.2967\/jnumed.125.271933","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:00:21Z","timestamp":1777561221000},"page":"1079-1085","source":"Crossref","is-referenced-by-count":0,"title":["Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [\n                    <sup>68<\/sup>\n                    Ga]Ga-OncoACP3-DOTA PET in Patients with Prostate Cancer"],"prefix":"10.2967","volume":"67","author":[{"given":"Julia","family":"Brosch-Lenz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"B\u00fcther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Oehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ciamarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Georgiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitas","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-J\u00f6rg","family":"Breyholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Schlack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"B\u00f6gemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Puca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Mock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Cazzamalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kambiz","family":"Rahbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres Jan","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sch\u00e4fers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin Egon","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Backhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"2026070106450730000_67.7.1079.1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol."},{"key":"2026070106450730000_67.7.1079.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.04.010"},{"key":"2026070106450730000_67.7.1079.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2026070106450730000_67.7.1079.4","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2014.77"},{"key":"2026070106450730000_67.7.1079.5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/JU.0000000000001369","article-title":"Detection rate of prostate specific membrane antigen tracers for positron emission tomography\/computerized tomography in prostate cancer biochemical recurrence: a systematic review and network meta-analysis","volume":"205","author":"Crocerossa","year":"2021","journal-title":"J Urol."},{"key":"2026070106450730000_67.7.1079.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00237-3"},{"key":"2026070106450730000_67.7.1079.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267416"},{"key":"2026070106450730000_67.7.1079.8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41551-025-01432-6","article-title":"Discovery of high-affinity ligands for prostatic acid phosphatase via DNA-encoded library screening enables targeted cancer therapy","volume":"10","author":"Georgiev","year":"2026","journal-title":"Nat Biomed Eng."},{"key":"2026070106450730000_67.7.1079.9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.eururo.2025.11.025","article-title":"Translational and first-in-human PET targeting the prostatic acid phosphatase (ACP3) in prostate cancer using the ligand [68Ga]Ga-OncoACP3-DOTA","volume":"89","author":"Backhaus","year":"2026","journal-title":"Eur Urol."},{"key":"2026070106450730000_67.7.1079.10","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s00259-024-06965-7","article-title":"Design, preclinical evaluation, and first-in-human PET study of [68Ga]Ga-PSFA-01: a PSMA\/FAP heterobivalent tracer","volume":"52","author":"Wang","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026070106450730000_67.7.1079.11","doi-asserted-by":"crossref","unstructured":"Ashraf B McKenzie J Armstrong AJ . Beyond PSMA: theranostic cell surface targets in metastatic prostate cancer. Prostate Cancer Prostatic Dis. October 4, 2025 [Epub ahead of print].","DOI":"10.1038\/s41391-025-01037-9"},{"key":"2026070106450730000_67.7.1079.12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-1651"},{"key":"2026070106450730000_67.7.1079.13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.62347\/DZIU5992","article-title":"Transmembrane prostatic acid phosphatase: a therapeutic target in advanced prostate cancer","volume":"12","author":"Kirschenbaum","year":"2024","journal-title":"Am J Clin Exp Urol."},{"key":"2026070106450730000_67.7.1079.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268011"},{"key":"2026070106450730000_67.7.1079.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264225"},{"key":"2026070106450730000_67.7.1079.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264230"},{"key":"2026070106450730000_67.7.1079.17","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-016-0942-0"},{"key":"2026070106450730000_67.7.1079.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1422-4"},{"key":"2026070106450730000_67.7.1079.19","doi-asserted-by":"publisher","DOI":"10.1177\/0146645316661077"},{"key":"2026070106450730000_67.7.1079.20","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.3390\/diagnostics13203242","article-title":"Diagnostic role and prognostic impact of PSAP immunohistochemistry: a tissue microarray study on 31,358 cancer tissues","volume":"13","author":"Tribian","year":"2023","journal-title":"Diagnostics."},{"key":"2026070106450730000_67.7.1079.21","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1097\/RLU.0000000000001349","article-title":"68Ga-PSMA-11 dynamic PET\/CT imaging in primary prostate cancer","volume":"41","author":"Sachpekidis","year":"2016","journal-title":"Clin Nucl Med."},{"key":"2026070106450730000_67.7.1079.22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13550-023-00981-8","article-title":"Multiparametric dynamic whole-body PSMA PET\/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007","volume":"13","author":"Dias","year":"2023","journal-title":"EJNMMI Res."},{"key":"2026070106450730000_67.7.1079.23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13550-023-01066-2","article-title":"Comparison of tracer kinetic models for 68Ga-PSMA-11 PET in intermediate-risk primary prostate cancer patients","volume":"14","author":"Smith","year":"2024","journal-title":"EJNMMI Res."},{"key":"2026070106450730000_67.7.1079.24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13550-020-0594-6","article-title":"Kinetic modeling of 68Ga-PSMA-11 and validation of simplified methods for quantification in primary prostate cancer patients","volume":"10","author":"Ringheim","year":"2020","journal-title":"EJNMMI Res."},{"key":"2026070106450730000_67.7.1079.25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/mp.16876","article-title":"Kinetic modeling and parametric imaging of 18F-PSMA-11: an evaluation based on total-body dynamic positron emission tomography scans","volume":"51","author":"Yuan","year":"2024","journal-title":"Med Phys."},{"key":"2026070106450730000_67.7.1079.26","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00259-018-3989-0","article-title":"18F-PSMA-1007 PET\/CT at 60 and 120 minutes in patients with prostate cancer: biodistribution, tumour detection and activity kinetics","volume":"45","author":"Rahbar","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026070106450730000_67.7.1079.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262290"},{"key":"2026070106450730000_67.7.1079.28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.252114"},{"key":"2026070106450730000_67.7.1079.29","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-015-0850-8"},{"key":"2026070106450730000_67.7.1079.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3573-4"},{"key":"2026070106450730000_67.7.1079.31","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1007\/s00259-016-3424-3","article-title":"Biodistribution and radiation dosimetry of 68Ga-PSMA HBED CC\u2014a PSMA specific probe for PET imaging of prostate cancer","volume":"43","author":"Pfob","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026070106450730000_67.7.1079.32","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3419-0"},{"key":"2026070106450730000_67.7.1079.33","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.161299"},{"key":"2026070106450730000_67.7.1079.34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jmrs.227","article-title":"Lutetium 177 PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy","volume":"64","author":"Emmett","year":"2017","journal-title":"J Med Radiat Sci."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.271933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:05:31Z","timestamp":1782914731000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.271933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,1]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.2967\/jnumed.125.271933"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.271933","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}